Objective: To evaluate the changes in cerebral blood flow during awake off-pump coronary artery bypass grafting and compare with the changes during off-pump coronary artery bypass grafting under general anesthesia, using continuous monitoring of regional cerebral oxygen saturation. Methods: The study population comprised 3 groups of patients who had undergone off-pump coronary artery bypass grafting with thoracic epidural anesthesia, general anesthesia, or a combination of the two. Regional brain oxygen saturation, determined with a near-infrared oxygen monitor, and mean arterial pressure during surgery were calculated and compared among the 3 groups. Results: Patients who had undergone awake off-pump coronary artery bypass grafting with thoracic epidural anesthesia had a significantly higher cerebrovascular impairment ratio, and the EuroSCORE was high. No significant differences were observed among the 3 groups in terms of the relationship between mean arterial pressure during surgery and regional brain oxygen saturation. It is suggested that there were no differences in cerebral blood flow and mean arterial pressure changes among the 3 groups. Conclusions: Awake off-pump coronary artery bypass grafting is a safe surgical technique for patients with history of cerebral infarction or impaired cerebral blood flow. Awake off-pump coronary artery bypass grafting is a less invasive procedure that allows efficient management of intraoperative cerebral blood flow, and can be equally effective as a percutaneous coronary intervention.
Introduction
Cerebral infarction is one of the serious complications that may develop after coronary bypass graft surgery (CABG). Off-pump coronary artery bypass (OPCAB) is associated with fewer post-surgical cerebral infarctions than conventional CABG. [1] [2] [3] [4] This difference is likely because conventional CABG may result in thrombi, air embolism, or intraoperative decreases in cerebral blood flow due to cardiopulmonary bypass. The incidence of postoperative cerebral infarction is 0.8%-2.4% in OPCAB patients. [1] [2] [3] [4] Age and cerebrovascular disease have been associated with increased risk of postoperative cerebral infarction. 3 Our aim was to reduce the incidence of postoperative cerebral infarction. Awake off-pump coronary artery bypass (AOCAB) is a novel intraoperative or perioperative management technique introduced by Karagoz and colleagues 5 in 2000. We have performed AOCAB under thoracic epidural anesthesia (TEA) in high-risk patients with a history of cerebral infarction, impaired cerebral blood flow, or severe pulmonary dysfunction since 2003. 6 In AOCAB, general anesthesia or tracheal intubation are unnecessary because spontaneous breathing can be maintained by high TEA alone. Thus cerebrovascular data can be collected from conscious patients, which enables effective monitoring. 7 It has been anticipated that AOCAB can be performed in high-risk patients with a history of cerebral infarction, impaired cerebral blood flow detected during preoperative examination, or poor respiratory function. However, there has been no study on cerebral blood flow during AOCAB with a comparison between AOCAB and OPCAB. In this study, we evaluated the changes in cerebral blood flow during AOCAB and OPCAB using continuous monitoring of regional cerebral oxygen saturation (rSO 2 ).
Patients and methods
This study was approved by the Kanazawa University Hospital Research Ethics Committee, and informed consent was obtained from all patients. Twenty-one patients were enrolled in this prospective nonrandomized study. The patients were divided into 3 groups: 7 patients who underwent AOCAB under epidural anesthesia alone (group A), 7 who underwent OPCAB with a combination of general and epidural anesthesia (group B), and 7 who underwent OPCAB under general anesthesia alone (group C). Group A was a high-risk group comprising patients with history of cerebral infarction or impaired cerebral blood flow determined during preoperative examination. All patients underwent a color Doppler ultrasound study of the carotid arteries prior to surgery. If the patient had carotid stenosis of 50% or more, they were assigned to group A; those in groups B and C did not have a history of cerebral infarction or impaired cerebral blood flow determined during preoperative examination. Table 1 shows the patient characteristics in each group. We used EuroSCORE (European System for Cardiac Operative Risk Evaluation) II as a predictive index of the operative risk of each patient. EuroSCORE II is a risk model that allows calculation of the risk of death after a heart operation. The model asks for 17 items of information about the patient, the state of the heart, and the proposed operation, and uses logistic regression to calculate the risk of death. 8 Groups A and B did not receive preoperative anticoagulants or antiplatelets therapy within 1 week before surgery; group C required anticoagulant therapy before surgery for unstable angina pectoris.
On the day before the surgery, a thoracic epidural catheter was inserted at the T1-2 or T2-3 level in group A and B patients by anesthesiologists in the operating room. We performed peridurography to confirm that the catheter was inserted in the epidural space. Continuous infusion of a mixture of 2% lidocaine (40 mL) and fentanyl (250 mg) was initiated in the operating room on the day of surgery. For group A patients, we began the AOCAB procedure after they had paralysis of the intercostal muscles, and after confirming the loss of cold/pain sensation in the appropriate areas, and abdominal breathing. group B patients were administered 1%-1.5% sevoflurane and continuously infused with a mixture of 2% lidocaine (40 mL) and fentanyl (250 mg) via the epidural catheter. An epidural catheter was not inserted in group C patients because they had received anticoagulants; these patients inhaled 1.5%-2% sevoflurane and received intravenous fentanyl during OPCAB. During surgery, we monitored cerebral blood flow with a near-infrared oxygen monitor (NIRO-300; Hamamatsu Photonics KK, Hamamatsu, Japan) and determined the rSO 2 . This device transcranially measures the tissue oxygenation index using a near-infrared spectrometer. This index is the ratio of oxygenated hemoglobin to total hemoglobin in the tissue, expressed as a percentage, and it was measured every 5 s before inducing anesthesia and until completion of surgery by attaching a probe to the patient's forehead. The mean tissue oxygenation was calculated and compared among the 3 groups at the following time points: before anesthesia, after anesthesia, and at the time of anastomosis to the left anterior descending, left circumflex, or right coronary artery.
S-100b is released into cerebrospinal fluid on damage to the cranial nerve system, or into the blood stream on disruption of the blood-brain barrier; therefore, S-100b has been reported to be a possible indicator of cranial nerve impairment. 9 We measured serous S-100b levels by enzyme-linked immunosorbent assay (YK150 Human S-100b ELISA kit; Fujinomiya, Japan) before surgery, in the ward immediately after surgery, and 1 and 3 days after surgery, and compared the levels among the 3 groups.
We measured heart rate (HR) and mean arterial pressure (MAP) during surgery by inserting a catheter into the radial artery, and determined pulmonary artery pressure and central venous pressure (CVP) by inserting a pulmonary artery catheter through the right internal jugular vein. HR and MAP, pulmonary artery pressure, CVP were also calculated and compared among the 3 groups before anesthesia, after anesthesia, and at the time of anastomosis to the left anterior descending, left circumflex, or right circumflex artery. Intravenous methoxamine hydrochloride was mainly administered to patients with decreased blood pressure during surgery, to keep MAP > 50 mm Hg.
Data are expressed as mean AE standard deviation. Statistical analysis was performed with Statistical Package for the Social Sciences software (SPSS, Chicago, IL, USA). Multiple comparisons were made using Fisher's exact test and the Steel-Dwass test. The level of significance was p < 0.05.
Results
The patient characteristics and operative data are shown in Table 2 . In group A, the ratio of cerebrovascular impairment and EuroSCORE II were significantly high, indicating high risk. No statistically significant differences were noted among the groups in terms of mean age, sex, weight, body surface area, hypertension, diabetes, myocardial infarction, or ejection fraction. None of the patients developed a new cerebral infarction or died in the perioperative stage. No patient in group A was converted to general anesthesia. Because patients became verbose, irritable, or their level of consciousness decreased when MAP decreased to 50 mm Hg or less, we administered a vasopressor in real time, and maintained normalized consciousness. There were no significant differences in terms of the amount of methoxamine hydrochloride used among 3 groups. In Table 3 , HR, MAP, pulmonary artery pressure, CVP, and rSO 2 before and after anesthesia and according to the anastomosis location are shown. Preanesthetic HR was significantly higher in group C than in the other groups, but there were no significant differences in any other parameter. There were no significant differences in hemodynamics during surgery among the 3 groups. The correlation between rSO 2 and MAP among the 3 groups is shown in scattergrams (Figures 1 and 2) . At MAP 60 mm Hg and above, rSO 2 was approximately constant regardless of MAP, and no significant relationship was observed between MAP and rSO 2 during surgery in all 3 groups (Figure 1 ). Thus at MAP 60 mm Hg and above, autoregulation was similarly maintained in all 3 groups (Figure 2 ). At MAP < 60 mm Hg, rSO 2 had an approximately direct proportional relationship to MAP, and no significant differences in relationship were observed between MAP and rSO 2 during surgery in all 3 groups. Although serous levels of S-100b were evaluated, no significant differences among the groups were observed (Table 4 ).
Discussion
In this study, it was possible to prove a relationship between MAP and cerebral blood flow during AOCAB by evaluating intraoperative cerebral blood flow using rSO 2 as an index. In AOCAB, cerebral blood flow is maintained by autoregulation at MAP 5 60 mm Hg. However, symptoms due to decreased cerebral blood flow are observed at MAP 4 50 mm Hg. Comparing OPCAB with AOCAB, although patients of groups B and C had no history of impaired cerebral blood flow, cerebral blood flow was maintained by autoregulation at MAP 5 60 mm Hg, but autoregulation was lost at MAP < 60 mm Hg, and as with AOCAB, the level of cerebral blood flow decreased as MAP decreased. When MAP decreased during AOCAB, considering also the necessity to maintain consciousness, we were able to successfully perform the surgery by using a vasopressor without converting to general anesthesia.
Cerebral autoregulation can maintain normal cerebral blood flow at an average pressure of 60-150 mm Hg. 10 Once out of that range, autoregulation does not function, and cerebral blood flow cannot be maintained. It has been suggested that an overly decreased level of cerebral blood flow can trigger cerebral infarction. According to our data, whether patients underwent surgery with epidural anesthesia, general anesthesia employing sevoflurane (which is said to increase cerebral blood flow), or a combination of the two, the level of cerebral blood flow decreased as MAP decreased. 11 Even in OPCAB, which is performed without using cardiopulmonary bypass, MAP remains under 50 mm Hg, causing the level of cerebral blood flow to remain low. This condition may be one of the reasons for incidences of cerebral infarction associated with OPCAB. Measuring cerebral blood flow using a near-infrared oxygen monitor is easy and quick. In AOCAB, by measuring cerebral blood flow and being aware of the patient's level of consciousness, impaired cerebral blood flow can be immediately detected and treated. AOCAB is a useful method for lowering the incidence of cerebral infarction and maintaining patient quality of life. It is also a promising ultra-minimally invasive method for high-risk patients with impaired cerebral blood flow.
Recently, several major thoracic procedures performed in awake patients have been reported. [5] [6] [7] To reduce the adverse effects of general anesthesia and the cost, TEA has been employed to perform awake thoracic surgery procedures. AOCAB is a novel intraoperative or perioperative management technique. This surgical method opens the door to surgical treatment for high-risk patients with serious diseases in whom general anesthesia is difficult, as well as allowing patients who opt for early recovery to return to normal living shortly after surgery with markedly improved quality of life. AOCAB has other advantages compared to OPCAB. We have reported that a hypercoagulable state at 5 days after the operation was suggested in OPCAB patients but not in those who had AOCAB. 12 We also demonstrated that AOCAB reduces the incidence of postoperative atrial fibrillation due to its inhibition of sympathetic activity without inhibiting vagal activity, which causes antiarrhythmic effects. 13 This study suggested that reduced incidences of postoperative atrial fibrillation in AOCAB are due to the effect of TEA. However, in the present study, the changes in cerebral blood flow were almost equivalent among the 3 groups, suggesting that TEA had hardly any influence. Continuous monitoring of rSO 2 is possible by attaching a probe to the patient's forehead. Near-infrared spectrometry and bispectral index are noninvasive methods to evaluate cerebral blood flow. 14 This method we used is simple, noninvasive, and can be achieved in real time; therefore, rSO 2 is measured during open heart surgery. 15, 16 In this study, rSO 2 changed quickly with mean blood pressure, especially when the heart was displaced. During anastomosis of the left circumflex artery, both mean blood pressure and rSO 2 decreased. However, since the rSO 2 probe can only be attached to the forehead, the area that can be monitored is limited to that perfused by the anterior cerebral artery. Therefore, it is necessary to develop a probe that allows monitoring of other areas.
S-100 protein is a neural-specific protein that can bind calcium. The S-100 protein consists of 2 subunits: a and b chains. The b-chain subunit is present in the glial cells or Schwann cells. S-100b can be a good indicator of cerebrovascular impairment because the blood level of S-100b increases after a cerebral event. 17, 18 However, in our study, no patients experienced cerebrovascular impairment after surgery, and most likely because of this result, there were no significant differences in the S-100b levels among the 3 groups. This trial had several limitations. First, the background of the 3 groups differed highly. All patients with impaired cerebral blood flow were enrolled in group A. It is necessary to conduct a study of matched patients, but this limitation is a result of our view that it is more effective to perform AOCAB in patients with impaired cerebral blood flow. Also, the size of the groups must be increased for a more refined study. In the future, a randomized study should be conducted with larger groups of matched patients.
We concluded that AOCAB is a safe surgical technique for the patients with a history of cerebral infarction or impaired cerebral blood flow. AOCAB is a less invasive operative procedure that allows efficient management of intraoperative cerebral blood flow, and can be equally effective as a percutaneous coronary intervention.
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